SynthesisJAMA ophthalmology2021
Association Between Visual Impairment and Depression in Patients Attending Eye Clinics: A Meta-analysis.
Synthesis in JAMA ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
69 citing papers in PubMed, 3 syntheses or guidelines pooled it, 99 citations in OpenAlex.
- Risk and protective factors associated with depressive symptoms in older adults with visual impairment: a systematic review.The Gerontologist · 2026Pooled it
- Anti-VEGFs for Diabetic Macular Oedema: Analysis of Efficacy, Safety, and Cost of More Durable Therapies from a Dutch Societal Perspective.Advances in therapy · 2025Pooled it
- Visual Impairment and Suicide Risk: A Systematic Review and Meta-Analysis.JAMA network open · 2024Pooled it
- Rasch analysis of the new general self efficacy scale: an evaluation of its psychometric properties in older adults with low vision.Health and quality of life outcomes · 2024Trial
- [Ophthalmological care of senior citizens in residential nursing facilities : Care gaps, the TOVIS study and ways to an improved ophthalmological care].Zeitschrift fur Gerontologie und Geriatrie · 2026Review
- Ophthalmic and psychiatric health: the overlooked connection between ocular diseases and mental disorders.Eye (London, England) · 2026Review
- Eight Voices in Darkness: using art to involve the public in research dissemination.Research involvement and engagement · 2026Article
- Associations of Social Determinants of Health Scores with Visual Impairment and Premature Death in Visually Impaired Adults: Insights from CHARLS-A Cohort Study.Healthcare (Basel, Switzerland) · 2026Article
- Recent Developments in Research to Make the World Better for People with Low Vision.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026Review
- The Evolving Landscape of Vision Rehabilitation: Current Status and Future Directions.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026Review
- Subjective and objective visual impairment and all-cause mortality in older US adults: the role of physical activity and depressive symptoms in NHANES 2007-2008.BMJ open ophthalmology · 2026Article
- Risk of Depression, Anxiety, and Suicidal Behavior in Older Adults With Severe Vision Loss.Journal of vitreoretinal diseases · 2026Article
- Portable AI-powered scanning slit-light device for low-cost eye disease screening.Scientific reports · 2026Article
- Risk of Suicide Among U.S. Adults With Work Disability.American journal of preventive medicine · 2026Article
- When eye disease affects the mind: Psychological burden and functioning in autoimmune ophthalmology.World journal of clinical cases · 2026Article
- Intrinsic capacity as an indicator of the risk of depression and anxiety: a prospective cohort study based on the UK Biobank.Frontiers in psychology · 2026Article
- Prevalence and factors associated with stigma among adults diagnosed with severe vision impairment in rural Mozambique.International health · 2025Article
- The economic impact of retinal diseases for which gene therapy is emerging: a systematic literature review.Health economics review · 2025Review
- Optic disc morphometrics as a potential ocular biomarker for depression: evidence from two cross-sectional cohort studies.Translational psychiatry · 2025Article
- Depression and its Association With Cataract Status and Self-Perceived Burden of Elderly Patients With Cataract.Actas espanolas de psiquiatria · 2025Article
9 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 5 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
importanceGiven that depression is treatable and some ocular diseases that cause visual loss are reversible, early identification and treatment of patients with visual impairment who are most at risk of depression may have an important influence on the well-being of these patients.
objectiveTo conduct a meta-analysis on the prevalence of depression in patients with visual impairment who regularly visit eye clinics and low vision rehabilitation services. DATA SOURCES: MEDLINE (inception to June 7, 2020) and Embase (inception to June 7, 2020) were searched. STUDY SELECTION: Studies that obtained data on the association between acquired visual impairment and depression among individuals aged 18 years or older were identified and included in this review. Exclusion criteria comprised inherited or congenital eye diseases, review studies, unpublished articles, abstracts, theses, dissertations, and book chapters. Four independent reviewers analyzed the results of the search and performed the selection and data extraction to ensure accuracy. DATA EXTRACTION AND SYNTHESIS: Meta-analyses of prevalence were conducted using random-intercept logistic regression models. This study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. MAIN OUTCOMES AND MEASURES: Proportion of depression.
resultsA total of 27 studies were included in this review, and all but 2 included patients older than 65 years. Among 6992 total patients (mean [SD] age, 76 [13.9] years; 4195 women [60%]) with visual impairment, in 1687 patients with depression, the median proportion of depression was 0.30 (range, 0.03-0.54). The random-effects pooled estimate was 0.25 (95% CI, 0.19-0.33) with high heterogeneity (95% predictive interval, 0.05-0.70). No patient characteristic, measured at the study level, influenced the prevalence of depression, except for the inclusion of patients with cognitive impairment (0.33; 95% CI, 0.28-0.38 in 14 studies vs 0.18; 95% CI, 0.11-0.30 in 13 studies that excluded this with major comorbidities; P = .008). The prevalence of depression was high both in clinic-based studies (in 6 studies, 0.34; 95% CI, 0.23-0.47) and in rehabilitation services (in 18 studies, 0.25; 95% CI, 0.18-0.33 vs other settings in 3 studies, 0.15; 95% CI, 0.05-0.38; P = .17), and did not vary by visual impairment severity of mild (in 8 studies, 0.24; 95% CI, 0.14-0.38), moderate (in 10 studies, 0.29; 95% CI, 0.21-0.39), and severe (in 5 studies, 0.29; 95% CI, 0.12-0.56; P = .51). CONCLUSIONS AND RELEVANCE: The results of this meta-analysis suggest that depression in patients with visual impairment is a common problem that should be recognized and addressed by the health care professionals treating these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.